Drugs / Cimifuga Racemosa
last change May 2019 re-read 9 days ago

Cimifuga Racemosa

Developed for
polycystic ovary syndrome
Investigated by
Federal University of Minas Gerais

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase not applicable1 trial
— NCT03786809 Jun 2016 → Apr 2019 — Federal University of Minas Gerais Completed No outcome recorded
Comparator or background therapy1 trial
Phase 4 NCT02352597 Comparator Jan 2013 → Jan 2015 polycystic ovary syndrome Cairo University Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as cimifuga racemosa “received phytoestrogen (20mg of cimifuga racemosa from day 1- 12)” NCT02352597 ↗
1

NCT03786809 ↗